Naturex reports excellent results for 2011

NATUREX, France, world leader in specialty plant-based ingredients, presented its annual consolidated sales for the year 2011: "2011 was a further year of strong growth for NATUREX, which recorded excellent levels of activity over all markets and in all geographic areas where the Group is established: +12.3% organic growth at constant scope and currency," the company summarized in a statement.

In October 2011, NATUREX performed the acquisition of BURGUNDY, specialised in the production and marketing of plant extracts for the nutraceutical, pharmaceutical and cosmetics industries, which sales have been consolidated from 1st October 2011. Thus the sales generated over the year 2011 amounted to 253.6 million euros, an increase of 12.0%. At constant scope and exchange rate, the growth in sales was 12.3%, in compliance with the published annual growth objective.

The activity of the 4th quarter of 2011 was in the same growth dynamic as the previous quarters and the integration of the activities of BURGUNDY within NATUREX generated additional revenue of 2.7 million euros. The sales for the 4th quarter of 2011 thus amounted to 62.4 million euros, up 12.0%.

"Growth was good in the different markets, the integration of the activities of BURGUNDY enabled to complete the offer in the fields of Nutrition & Health and Personal Care," the company informed.

The Nutrition & Health activity increased by 11.9%, for a turnover of 84.5 million euros and includes 2.3 million euros from the nutraceuticals activity of BURGUNDY. The Personal Care activity recorded a turnover of 3.0 million euros, up 11.0% and includes 0.4 million euros of sales generated by BURGUNDY.

The emerging markets of Eastern Europe, Asia, Latin America, Africa and the Middle East which represented 14% of the Group’s sales over 2011, compared with less than 10% one year previously, offer highly promising development prospects.